PMDA drug package insert
アロチノロール塩酸塩錠5mg「サワイ」
PMDA Prescription drug · 沢井製薬株式会社 · package insert Aug 23, 2024
Key facts
| Brand names | アロチノロール塩酸塩錠5mg「サワイ」, アロチノロール塩酸塩錠10mg「サワイ」 |
|---|---|
| Nonproprietary names | アロチノロール塩酸塩 |
| Companies | 製造販売元／沢井製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 高血圧症・狭心症・不整脈治療剤; 本態性振戦治療剤 |
| Therapeutic category codes | 872123 |
| YJ codes | 2123014F1116, 2123014F2228 |
| Approval numbers | 22400AMX01431000, 22400AMX01432000 |
| Package insert edition | 第1版 |
| Package insert date | Aug 23, 2024 |
| PMDA document key | 300119_2123014F1116_1 |
| PMDA company code | 300119 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: